Preliminary Evaluation of an Injectable Therapeutic for Cisplatin Ototoxicity Using Neuronal SH-SY5Y Cells

Michelle Hong, Katherine Kedeshian, Larry Hoffman, Ashley Kita, Hiroshi Sakagami, Fumiaki Uchiumi · 2025

Read Preliminary Evaluation of an Injectable Therapeutic for Cisplatin Ototoxicity Using Neuronal SH-SY5Y Cells by Michelle Hong, Katherine Kedeshian, Larry Hoffman, Ashley Kita, Hiroshi Sakagami, Fumiaki Uchiumi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12735174.txt.

Description

Michelle Hong and co-authors present a 2025 lab study on shielding hearing from a common chemotherapy drug. Cisplatin saves lives but often damages the inner ear's nerve cells. The team used a human nerve-like cell line as a stand-in for those ear neurons to screen protective drugs quickly.

Four candidates were tested alongside the chemotherapy agent. Only one, N-acetylcysteine, kept the cells alive at the winning dose. The winners then loaded the drug into tiny biodegradable particles of varied recipes. Release curves were tracked over two months to find a slow, steady profile. Such particles could one day be injected near the ear for lasting protection. The study is an early step, in dishes rather than patients.

Catalog record

CREATORMichelle Hong, Katherine Kedeshian, Larry Hoffman, Ashley Kita, Hiroshi Sakagami, Fumiaki Uchiumi
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE38 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12735174

Browse the full library · About the Tower of Babel